secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001398733-25-000030
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics files Q3 2025 investor presentation; no specific financial details disclosed in filing text
--------------------------------------------------------------------------------

- Form 8-K filed on November 6, 2025, under Item 7.01 for Regulation FD disclosure.
- Investor presentation attached as Exhibit 99.1, titled 'Q3 Earnings Supplemental Materials'.
- Presentation available on company's website, but full content not included in provided filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873325000030/0001398733-25-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873325000030/aqst-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001398733-25-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer